At Stellar Performance Medical, programs begin with a full assessment and may include nutrition guidance and supportive therapies
The April 30, 2026 FDA proposal would further close the 503B bulks pathway permanently
Common adverse effects include nausea, diarrhea, vomiting, and constipation, which are typical for medications affecting gastrointestinal hormones
If you frequently struggle with adherence, talk to your provider about switching to a daily oral formulation or using genetic testing to optimize your personalized protocol
Off-label use of certain therapies, such as peptides, may be beneficial in managing metabolic syndrome, even if the patients BMI is not above 30
Regular review ensures that treatment remains appropriate, effective, and safe throughout the duration of therapy